Home NDC 50242-145 PERJETA
Product NDC 50242-145
11-digit product format 502420145
Labeler code 50242
Product ID 50242-145_dfebfe9c-a0c5-41d8-bf11-ed643627e264
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Pertuzumab
Dosage form INJECTION, SOLUTION, CONCENTRATE
Route INTRAVENOUS
Labeler Genentech, Inc.
Application BLA125409
Marketing category BLA
Marketing start 2012-06-08
Substance PERTUZUMAB
Active strength 30 mg/mL
Pharmacologic classes HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base PERJETA
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength PERTUZUMAB 30 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination K16AIQ8CTM Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1298948 Internal RxNorm lookup 1298953 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 50242-145-01 PERJETA 14 mL in 1 VIAL, SINGLE-USE INJECTION, SOLUTION, CONCENTRATE 14 27 50242-145-01 PERJETA 1 in 1 CARTON INJECTION, SOLUTION, CONCENTRATE 1 27
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded Pertuzumab ACTIVE INGREDIENT K16AIQ8CTM PERJETA (PERTUZUMAB) INJECTION, SOLUTION, CONCENTRATE [GENENTECH, INC.] 5 Pertuzumab ACTIVE MOIETY K16AIQ8CTM PERJETA (PERTUZUMAB) INJECTION, SOLUTION, CONCENTRATE [GENENTECH, INC.] 5 acetic acid INACTIVE INGREDIENT Q40Q9N063P PERJETA (PERTUZUMAB) INJECTION, SOLUTION, CONCENTRATE [GENENTECH, INC.] 5 histidine INACTIVE INGREDIENT 4QD397987E PERJETA (PERTUZUMAB) INJECTION, SOLUTION, CONCENTRATE [GENENTECH, INC.] 5 polysorbate 20 INACTIVE INGREDIENT 7T1F30V5YH PERJETA (PERTUZUMAB) INJECTION, SOLUTION, CONCENTRATE [GENENTECH, INC.] 5 sucrose INACTIVE INGREDIENT C151H8M554 PERJETA (PERTUZUMAB) INJECTION, SOLUTION, CONCENTRATE [GENENTECH, INC.] 5 water INACTIVE INGREDIENT 059QF0KO0R PERJETA (PERTUZUMAB) INJECTION, SOLUTION, CONCENTRATE [GENENTECH, INC.] 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50242-145 PERJETA (PERTUZUMAB) INJECTION, SOLUTION, CONCENTRATE [GENENTECH, INC.] 22 Current NDC, Legacy NDC, 2 package rows 20250509_17f85d17-ab71-4f5b-9fe3-0b8c822f69ff.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 125409 Perjeta pertuzumab 351(a) Rx 2026-07-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 50242-145-01 50242014501 1 VIAL, SINGLE-USE in 1 CARTON (50242-145-01) / 14 mL in 1 VIAL, SINGLE-USE 2012-06-08 0000-00-00 No No Current